Applications of phenyliodine( III ) diacetate in heterocyclic ring formations: An update from 2015 to date
Journal of Heterocyclic Chemistry · 2023-08 · 60 (8) · 1326-1355
DOI: 10.1002/jhet.4627 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Heterocyclic Chemistry, online erschienen am 15.02.2023. Verfasst von Mohammed Mujahid Alam und 6 weiteren Autor:innen. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: King Khalid University.
Abstract (Originalsprache)
Diacetoxyiodobenzene ( PhI ( OAc ) 2 ), commonly referred to as DAIB or phenyliodine( III ) diacetate ( PIDA ), is one of the most frequently used hypervalent iodines employed as an oxidizing agent in organic chemistry. In this review, PIDA is highlighted exclusively in relation to its applications in organic synthesis involving heterocyclic ring formations and is critically and in‐depth examined from the summer of 2015 to the present with a specific focus on the mechanistic pathway.
Förderung
- King Khalid University
Zitieren
APA
Alam, M. M., Hussien, M., Bollikolla, H. B., Seema, V., Dubasi, N., Amanullah, M., & Varala, R. (2023). Applications of phenyliodine( III ) diacetate in heterocyclic ring formations: An update from 2015 to date. Journal of Heterocyclic Chemistry, 60(8), 1326-1355. https://doi.org/10.1002/jhet.4627
Vancouver
Alam MM, Hussien M, Bollikolla HB, Seema V, Dubasi N, Amanullah M, et al. Applications of phenyliodine( III ) diacetate in heterocyclic ring formations: An update from 2015 to date. Journal of Heterocyclic Chemistry. 2023;60(8):1326-1355. doi:10.1002/jhet.4627
BibTeX
@article{Alam2023,
author = {Alam, Mohammed Mujahid and Hussien, Mohamed and Bollikolla, Hari Babu and Seema, Vittal and Dubasi, Narsimhaswamy and Amanullah, Mohammed and Varala, Ravi},
title = {Applications of phenyliodine( III ) diacetate in heterocyclic ring formations: An update from 2015 to date},
journal = {Journal of Heterocyclic Chemistry},
year = {2023},
volume = {60},
number = {8},
pages = {1326--1355},
doi = {10.1002/jhet.4627}
}
EUVIMED